Dendritic cell immunoreceptor 2 (DCIR2) deficiency decreases hepatic conventional dendritic cell content but not the progression of diet‐induced obesity
Abstract Aims Inflammatory pathways and immune system dysregulation participate in the onset and progression of cardiometabolic diseases. The dendritic cell immunoreceptor 2 (DCIR2) is a C‐type lectin receptor mainly expressed by conventional type 2 dendritic cells, involved in antigen recognition a...
Main Authors: | Rossella Bellini, Annalisa Moregola, Jasmine Nour, Patrizia Uboldi, Fabrizia Bonacina, Giuseppe D. Norata |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-10-01
|
Series: | Immunity, Inflammation and Disease |
Subjects: | |
Online Access: | https://doi.org/10.1002/iid3.1024 |
Similar Items
-
Dendritic cell marker Clec4a4 deficiency limits atherosclerosis progression
by: Rossella Bellini, et al.
Published: (2023-03-01) -
Skin Delivery of Clec4a Small Hairpin RNA Elicited an Effective Antitumor Response by Enhancing CD8+ Immunity In Vivo
by: Tzu-Yang Weng, et al.
Published: (2017-12-01) -
Ligand binding and signaling of dendritic cell immunoreceptor (DCIR) is modulated by the glycosylation of the carbohydrate recognition domain.
by: Karien Bloem, et al.
Published: (2013-01-01) -
Characterization of the Porcine CLEC12A and Analysis of Its Expression on Blood Dendritic Cell Subsets
by: Belén Álvarez, et al.
Published: (2020-05-01) -
Dendritic cell immunoreceptor is a new target for anti-AIDS drug development: identification of DCIR/HIV-1 inhibitors.
by: Alexandra A Lambert, et al.
Published: (2013-01-01)